AQR Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.15M Buy
125,979
+120,594
+2,239% +$2.06M ﹤0.01% 1730
2025
Q1
$344K Buy
5,385
+3,671
+214% +$234K ﹤0.01% 2628
2024
Q4
$208K Buy
+1,714
New +$208K ﹤0.01% 2657
2023
Q4
Sell
-8,422
Closed -$1.02M 2439
2023
Q3
$1.02M Sell
8,422
-1,299
-13% -$157K ﹤0.01% 1590
2023
Q2
$1.11M Buy
9,721
+1,829
+23% +$209K ﹤0.01% 1508
2023
Q1
$1.09M Buy
7,892
+5,066
+179% +$698K ﹤0.01% 1509
2022
Q4
$366K Buy
2,826
+95
+3% +$12.3K ﹤0.01% 1918
2022
Q3
$302K Buy
+2,731
New +$302K ﹤0.01% 1943
2021
Q1
Sell
-4,834
Closed -$824K 2263
2020
Q4
$824K Sell
4,834
-180
-4% -$30.7K ﹤0.01% 1588
2020
Q3
$704K Buy
5,014
+3,158
+170% +$443K ﹤0.01% 1583
2020
Q2
$298K Sell
1,856
-2,836
-60% -$455K ﹤0.01% 1885
2020
Q1
$459K Sell
4,692
-1,190
-20% -$116K ﹤0.01% 1608
2019
Q4
$759K Sell
5,882
-1,754
-23% -$226K ﹤0.01% 1605
2019
Q3
$575K Sell
7,636
-8,784
-53% -$661K ﹤0.01% 1706
2019
Q2
$2.5M Sell
16,420
-4,957
-23% -$753K ﹤0.01% 1190
2019
Q1
$2.55M Buy
21,377
+1,196
+6% +$143K ﹤0.01% 1218
2018
Q4
$2.2M Sell
20,181
-5,437
-21% -$593K ﹤0.01% 1213
2018
Q3
$4.14M Sell
25,618
-45,231
-64% -$7.31M ﹤0.01% 1079
2018
Q2
$9.37M Sell
70,849
-17,427
-20% -$2.3M 0.01% 809
2018
Q1
$6.54M Buy
88,276
+16,176
+22% +$1.2M 0.01% 902
2017
Q4
$4.01M Sell
72,100
-9,368
-11% -$521K ﹤0.01% 1113
2017
Q3
$3.7M Buy
81,468
+28,600
+54% +$1.3M ﹤0.01% 1148
2017
Q2
$1.78M Buy
52,868
+501
+1% +$16.9K ﹤0.01% 1435
2017
Q1
$1.55M Buy
52,367
+10,648
+26% +$315K ﹤0.01% 1496
2016
Q4
$1.14M Buy
41,719
+36,738
+738% +$1.01M ﹤0.01% 1660
2016
Q3
$306K Buy
+4,981
New +$306K ﹤0.01% 2075
2016
Q2
Sell
-23,268
Closed -$454K 2256
2016
Q1
$454K Sell
23,268
-8,932
-28% -$174K ﹤0.01% 1873
2015
Q4
$1.24M Buy
32,200
+15,125
+89% +$583K ﹤0.01% 1479
2015
Q3
$548K Buy
+17,075
New +$548K ﹤0.01% 1680
2014
Q1
Sell
-32,000
Closed -$652K 2623
2013
Q4
$652K Sell
32,000
-14,488
-31% -$295K ﹤0.01% 1931
2013
Q3
$2.2M Buy
46,488
+16,115
+53% +$761K 0.01% 1233
2013
Q2
$1.16M Buy
+30,373
New +$1.16M ﹤0.01% 1495